Report Detail
Global (United States, European Union and China) HPAPI (High Potency Active Pharmaceutical Ingredients) Market Research Report 2019-2025
- RnM3682148 |
- 19 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Other
High potency active pharmaceutical ingredients are used in targeted therapeutics and show effective treatment even at extremely low concentration. These APIs are difficult to manufacture and require technological expertise and sophisticated manufacturing setup. HPAPI market currently accounts for a small portion of overall API market, however is a rapidly growing segment.
In 2019, the market size of HPAPI (High Potency Active Pharmaceutical Ingredients) is 16600 million US$ and it will reach 32200 million US$ in 2025, growing at a CAGR of 8.7% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for HPAPI (High Potency Active Pharmaceutical Ingredients).
This report studies the global market size of HPAPI (High Potency Active Pharmaceutical Ingredients), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the HPAPI (High Potency Active Pharmaceutical Ingredients) production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Alkermes
Cambrex
Dishman
Dr. Reddy’S
Lonza
Novasep
Thermofisher Scientific
Pfizer
Merck
Teva Pharmaceutical
Market Segment by Product Type
Innovative HPAPI
Generic HPAPI
Market Segment by Application
Captive HPAPI
Merchant HPAPI
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the HPAPI (High Potency Active Pharmaceutical Ingredients) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key HPAPI (High Potency Active Pharmaceutical Ingredients) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of HPAPI (High Potency Active Pharmaceutical Ingredients) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Innovative HPAPI
- 1.3.3 Generic HPAPI
- 1.4 Market Segment by Application
- 1.4.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Share by Application (2019-2025)
- 1.4.2 Captive HPAPI
- 1.4.3 Merchant HPAPI
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production Value 2014-2025
- 2.1.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production 2014-2025
- 2.1.3 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Capacity 2014-2025
- 2.1.4 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Size CAGR of Key Regions
- 2.2.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Capacity by Manufacturers
- 3.1.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue by Manufacturers (2014-2019)
- 3.2.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Concentration Ratio (CR5 and HHI)
- 3.3 HPAPI (High Potency Active Pharmaceutical Ingredients) Price by Manufacturers
- 3.4 Key Manufacturers HPAPI (High Potency Active Pharmaceutical Ingredients) Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into HPAPI (High Potency Active Pharmaceutical Ingredients) Market
- 3.6 Key Manufacturers HPAPI (High Potency Active Pharmaceutical Ingredients) Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Innovative HPAPI Production and Production Value (2014-2019)
- 4.1.2 Generic HPAPI Production and Production Value (2014-2019)
- 4.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production Market Share by Type
- 4.3 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production Value Market Share by Type
- 4.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Application
6 Production by Regions
- 6.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production (History Data) by Regions 2014-2019
- 6.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States HPAPI (High Potency Active Pharmaceutical Ingredients) Production Growth Rate 2014-2019
- 6.3.2 United States HPAPI (High Potency Active Pharmaceutical Ingredients) Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States HPAPI (High Potency Active Pharmaceutical Ingredients) Import & Export
- 6.4 European Union
- 6.4.1 European Union HPAPI (High Potency Active Pharmaceutical Ingredients) Production Growth Rate 2014-2019
- 6.4.2 European Union HPAPI (High Potency Active Pharmaceutical Ingredients) Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union HPAPI (High Potency Active Pharmaceutical Ingredients) Import & Export
- 6.5 China
- 6.5.1 China HPAPI (High Potency Active Pharmaceutical Ingredients) Production Growth Rate 2014-2019
- 6.5.2 China HPAPI (High Potency Active Pharmaceutical Ingredients) Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China HPAPI (High Potency Active Pharmaceutical Ingredients) Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Regions
- 7.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Type
- 7.2.2 United States HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Application
- 7.3 European Union
- 7.3.1 European Union HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Type
- 7.3.2 European Union HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Application
- 7.4 China
- 7.4.1 China HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Type
- 7.4.2 China HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Type
- 7.5.2 Rest of World HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Alkermes
- 8.1.1 Alkermes Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 8.1.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 8.1.5 Alkermes Recent Development
- 8.2 Cambrex
- 8.2.1 Cambrex Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 8.2.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 8.2.5 Cambrex Recent Development
- 8.3 Dishman
- 8.3.1 Dishman Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 8.3.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 8.3.5 Dishman Recent Development
- 8.4 Dr. Reddy’S
- 8.4.1 Dr. Reddy’S Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 8.4.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 8.4.5 Dr. Reddy’S Recent Development
- 8.5 Lonza
- 8.5.1 Lonza Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 8.5.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 8.5.5 Lonza Recent Development
- 8.6 Novasep
- 8.6.1 Novasep Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 8.6.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 8.6.5 Novasep Recent Development
- 8.7 Thermofisher Scientific
- 8.7.1 Thermofisher Scientific Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 8.7.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 8.7.5 Thermofisher Scientific Recent Development
- 8.8 Pfizer
- 8.8.1 Pfizer Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 8.8.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 8.8.5 Pfizer Recent Development
- 8.9 Merck
- 8.9.1 Merck Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 8.9.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 8.9.5 Merck Recent Development
- 8.10 Teva Pharmaceutical
- 8.10.1 Teva Pharmaceutical Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of HPAPI (High Potency Active Pharmaceutical Ingredients)
- 8.10.4 HPAPI (High Potency Active Pharmaceutical Ingredients) Product Introduction
- 8.10.5 Teva Pharmaceutical Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Capacity, Production Forecast 2019-2025
- 9.1.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production Forecast by Type
- 9.7.2 Global HPAPI (High Potency Active Pharmaceutical Ingredients) Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 HPAPI (High Potency Active Pharmaceutical Ingredients) Sales Channels
- 10.2.2 HPAPI (High Potency Active Pharmaceutical Ingredients) Distributors
- 10.3 HPAPI (High Potency Active Pharmaceutical Ingredients) Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on HPAPI (High Potency Active Pharmaceutical Ingredients). Industry analysis & Market Report on HPAPI (High Potency Active Pharmaceutical Ingredients) is a syndicated market report, published as Global (United States, European Union and China) HPAPI (High Potency Active Pharmaceutical Ingredients) Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of HPAPI (High Potency Active Pharmaceutical Ingredients) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
